Helix Platform Granted the 1st and Only FDA Authorization for a Whole Exome Sequencing Platform
Helix advises this marks the first time such a broad, sequencing-based device has been authorized by the FDA.
Medical Device News Magazine reports breaking biotechnology news including new biotech developments, pharmaceuticals and more.
Helix advises this marks the first time such a broad, sequencing-based device has been authorized by the FDA.
This new detection method represents a great step forward in determining if patients have had COVID-19 and if they might still have immunity to the disease.
CareVax is being released in the US first, internationally in early Q1, and is poised to work with government public health agencies at the federal, state, local county, and city levels offering a data-driven solution that can provide real-time analytic, surveillance and market intelligence in order to make more informed care decisions.
The company notes the test will provide health professionals with accurate detection of the nucleoprotein of the SARS-CoV-2 virus in respiratory swabs, within 10 minutes.
The company advises this EUA amendment will allow 3B BlackBio Biotech’s North American distributor, Genophyll Enterprises, to expand saliva COVID-19 PCR-based viral diagnostic testing across the U.S. as well as from their upcoming New Jersey-based laboratory.
Briotech notes that in addition to its flagship product, Briotech Topical Skin Spray, Briotech produces Super Oxidized Saline for oral use, and an EPA approved Multi Surface Sanitizer + Disinfectant effective against coronavirus (the novel SARS-CoV-2 pandemic virus that causes COVID-19).